Influence of comorbid alcohol use disorder on treatment response of depressive patients
- 539 Downloads
Patients with major depressive disorder (MDD) frequently also have alcohol use disorder (AUD) and they are more likely to experience symptomatic recurrence and resist treatment. How the two disorders interrelate has not yet been fully examined in Japanese subjects. The treatment response of 47 MDD patients was followed for 12 weeks. Depressive symptoms were rated by the 17-item Hamilton Rating Scale for Depression (HAM-D) and those whose HAM-D score was less than 16 were excluded. The MDD patients were divided into a non-alcohol use disorder (NAUD) and an alcohol use disorder (AUD) group according to the Alcohol Use Disorder Identification Test (AUDIT). We applied a cutoff score of 12 in the AUDIT scale. After 8 weeks, HAM-D NAUD group scores were significantly lower compared with AUD patients. The NAUD group, 23 individuals, prescribed therapeutic doses of antidepressant (equivalent to more than 150 mg of imipramine per day) significantly improved their HAM-D scores but no improvement occurred in the AUD subjects. Correlation analysis in all subjects revealed a significant negative correlation between AUDIT score and improved HAM-D score at endpoint. Moreover, a significant negative correlation was found between total alcohol consumption during the study period and improvement of HAM-D score at endpoint in AUD patients. These results suggest that co-occurrence of MDD and AUD is associated with a lower response to antidepressant treatment and it may reflect an inhibitory effect of ethanol on antidepressants action in the brain.
KeywordsAlcohol use disorder Depression Comorbidity Antidepressant
We thank Dr. Tomonobu Sirasaka (Ishibashi Hospital Otaru, Japan), Dr. Kenji Yanbe (Asahiyama Hospital, Sapporo, Japan), Dr. Kimihiro Nakajima (Goryokai Hospital, Sapporo, Japan), Dr. Jiro Miyazawa (Tokiwa Hospital, Sapporo, Japan), and Dr. Tomonari Irie (Nakae Hospital, Sapporo, Japan).
- Bertolote JM, Fleischmann A (2002) Suicide and psychiatric diagnosis: a worldwide perspective. World Psychiat Off J World Psychiatric Assoc (WPA) 1:181–185Google Scholar
- Bremner JD (2002) Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectr 7(129–130):135–139Google Scholar
- Hiro H, Shima S (1996) Availability of the Alochol Use Disorders Identification Test (AUDIT) for a complete health examination in Japan. Jpn J Alcohol Drug Depend 31:437–450 (in Japanese)Google Scholar
- Hiro H, Shima S (1997) The effectiveness of CAGE and AUDIT in the detection of problem drinkers. Jpn J Clin Med 55:589–593 (in Japanese)Google Scholar
- Inagaki A, Inada T (2006) Dose equivalence of psychotropic drugs. Part X VIII: dose equivalence of psychotropic drugs: 2006-Version. Jpn J Clin Psychopharmacol 9:1443–1447 (in Japanese)Google Scholar
- Kessler RC, Crum RM, Warner LA et al (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 53:232–240Google Scholar
- Saunders JB, Aasland OG, Babor TF et al (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiciton (Abingdon, England) 88:791–804Google Scholar
- Ukai W, Ishii T, Hashimoto E et al (2009) The common aspects of pathophysiology of alcoholism and depression. Jap J Alcohol Drug Dependence 44:704–711Google Scholar
- World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines, GenevaGoogle Scholar